Finding Description
Based on record review and interview, the facility failed to administer medication as ordered for one (#30) of five sampled residents reviewed for unnecessary medications.
The Administrator identified 80 residents resided in the facility. Regional Nurse Consultant #1 identified 15 residents who received insulin in the facility.
Findings:
A Specific Medication Administration Procedures policy, effective 01/22, read in part, .To administer medications via subcutaneous .routes in a safe, accurate, and effective manner .Check the order on the medication administration record to see that an injection is currently ordered and due .Document administration .
Resident #30 had diagnoses which included type two diabetes mellitus with unspecified complications and for type 2 diabetes mellitus with diabetic chronic kidney disease.
A Physician's order, dated 01/23/24, documented Humalog injection solution inject 5 units intramuscularly with meals related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 01/23/24, documented Humalog injection solution inject as per sliding scale intramuscularly before meals and at bedtime related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 05/16/24, documented insulin glargine subcutaneous solution 100 unit/ml inject 50 unit subcutaneously one time a day related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 07/16/24, documented Lantus Solostar subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously at bed time for type 2 diabetes mellitus with diabetic chronic kidney disease.
The August MAR documented the following blanks:
a. Humalog injection solution inject 5 units intramuscularly on the 3rd, 7th, 23rd, and the 26th at 1200 p.m.,
b. Humalog injection solution inject as per sliding scale intramuscularly on the 3rd and the 7th at 12:00 p.m., the 15th at 8:00 p.m., and the 30th at 8:00 p.m., and
c. Lantus Solostar subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously on the 30th at 8:00 p.m.
The September MAR documented the following blanks:
a. Humalog injection solution inject 5 units intramuscularly on the 5th at 8:00 a.m. and 12:00 p.m.,
b. Humalog injection solution inject as per sliding scale intramuscularly on the 5th at 8:00 a.m. and 12:00 p.m., and on the 6th at 8:00 p.m., and
c. insulin galrgine subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously on the 5th for the 7:00 a.m. to 11:00 a.m. medication administration.
On 09/16/24 at 1:44 p.m., LPN #2 stated the policy for administering insulin to residents was to administer per physician's orders. LPN #2 reviewed the administration record for Resident #30. They stated the blanks on the insulin administration record meant it was not given.
On 09/16/24 at 1:55 p.m., the DON stated the policy for insulin administration depended on the physician's orders. They stated the blanks on the insulin administration record could be a variety of things. The DON was informed of the blanks on the August and September MAR and was provided opportunity to provide documentation for the blanks.
On 09/16/24 at 2:44 p.m., the DON provided documentation of resident being out of the facility on 09/15/24 during the 8:00 a.m. and 12:00 p.m. insulin administration times. They could not provide documentation for the above blanks.
The Administrator identified 80 residents resided in the facility. Regional Nurse Consultant #1 identified 15 residents who received insulin in the facility.
Findings:
A Specific Medication Administration Procedures policy, effective 01/22, read in part, .To administer medications via subcutaneous .routes in a safe, accurate, and effective manner .Check the order on the medication administration record to see that an injection is currently ordered and due .Document administration .
Resident #30 had diagnoses which included type two diabetes mellitus with unspecified complications and for type 2 diabetes mellitus with diabetic chronic kidney disease.
A Physician's order, dated 01/23/24, documented Humalog injection solution inject 5 units intramuscularly with meals related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 01/23/24, documented Humalog injection solution inject as per sliding scale intramuscularly before meals and at bedtime related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 05/16/24, documented insulin glargine subcutaneous solution 100 unit/ml inject 50 unit subcutaneously one time a day related to type two diabetes mellitus with unspecified complications.
A Physician's order, dated 07/16/24, documented Lantus Solostar subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously at bed time for type 2 diabetes mellitus with diabetic chronic kidney disease.
The August MAR documented the following blanks:
a. Humalog injection solution inject 5 units intramuscularly on the 3rd, 7th, 23rd, and the 26th at 1200 p.m.,
b. Humalog injection solution inject as per sliding scale intramuscularly on the 3rd and the 7th at 12:00 p.m., the 15th at 8:00 p.m., and the 30th at 8:00 p.m., and
c. Lantus Solostar subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously on the 30th at 8:00 p.m.
The September MAR documented the following blanks:
a. Humalog injection solution inject 5 units intramuscularly on the 5th at 8:00 a.m. and 12:00 p.m.,
b. Humalog injection solution inject as per sliding scale intramuscularly on the 5th at 8:00 a.m. and 12:00 p.m., and on the 6th at 8:00 p.m., and
c. insulin galrgine subcutaneous solution pen-injector 100 unit/ml inject 60 unit subcutaneously on the 5th for the 7:00 a.m. to 11:00 a.m. medication administration.
On 09/16/24 at 1:44 p.m., LPN #2 stated the policy for administering insulin to residents was to administer per physician's orders. LPN #2 reviewed the administration record for Resident #30. They stated the blanks on the insulin administration record meant it was not given.
On 09/16/24 at 1:55 p.m., the DON stated the policy for insulin administration depended on the physician's orders. They stated the blanks on the insulin administration record could be a variety of things. The DON was informed of the blanks on the August and September MAR and was provided opportunity to provide documentation for the blanks.
On 09/16/24 at 2:44 p.m., the DON provided documentation of resident being out of the facility on 09/15/24 during the 8:00 a.m. and 12:00 p.m. insulin administration times. They could not provide documentation for the above blanks.